Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort.
about
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.HER-3 targeting alters the dimerization pattern of ErbB protein family members in breast carcinomas.Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic modelsPro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expressionQuantitative assessment of miR34a as an independent prognostic marker in breast cancer.Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer.Role of ErbB Receptors in Cancer Cell Migration and InvasionLoss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.SMURF1 plays a role in EGF-induced breast cancer cell migration and invasion.Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer.AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker.Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin.Prognostic significance of HER3 in patients with malignant solid tumors.HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients.Significance of EGFR Expression in Circulating Tumor Cells.Vaccination targeting human HER3 alters the phenotype of infiltrating T cells and responses to immune checkpoint inhibition.Loss of Anti-HER-3 CD4+ T-Helper Type 1 Immunity Occurs in Breast Tumorigenesis and is Negatively Associated with Outcomes.Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancerNuclear PKM2 promotes the progression of oral squamous cell carcinoma by inducing EMT and post-translationally repressing TGIF2
P2860
Q34483533-C78EE5A5-5F2C-4D0C-8B61-356F10957D40Q34506951-007600B0-9D43-435A-AC32-1CDF4F2BD9FFQ34988987-399811FF-BAA0-4F39-B7A8-C7285078D953Q35558942-F5BD1F02-1F27-4713-B4C1-F50D570C4785Q35677744-56412C29-06C4-4424-8E45-ABD086E29FA3Q36080919-8224E70E-E1C8-43F5-AFC0-12C6E7CF912BQ36311027-A32AD06B-CAD4-49A2-A5B1-64048636ABBCQ36910437-3D30537F-A05B-4513-8B97-2AD0F71FC3ADQ37462623-C4364B97-736D-4B12-BFD5-2CA9C47EC171Q37654672-7327EA7B-508C-4219-B735-D312F774CC38Q39357739-9A6A9F3D-C9D2-43C0-B98E-723F73C068E0Q39499017-6771A66B-27B7-4C75-BEA4-16AC98322ED7Q42148898-1670FE1F-DD1C-4BD4-9DD5-0AB99459FA0DQ50949577-C77276EB-6C04-4DC2-BD15-B4786B37B00DQ50969676-933B6DEC-6EFF-4F0A-AEED-82F474D05235Q52763519-408BB0E5-36F7-4B26-994B-5510F93EE150Q52909381-229A61E3-217A-492B-ABFA-2C8E36EFAD07Q58112887-B8E27928-58DF-4FB6-B7F9-8C570AF8F833Q58554069-DE40CD5C-3A6A-4B98-A6BF-4DF04415C2CB
P2860
Quantitative multiplexed analysis of ErbB family coexpression for primary breast cancer prognosis in a large retrospective cohort.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Quantitative multiplexed analy ...... a large retrospective cohort.
@en
Quantitative multiplexed analy ...... a large retrospective cohort.
@nl
type
label
Quantitative multiplexed analy ...... a large retrospective cohort.
@en
Quantitative multiplexed analy ...... a large retrospective cohort.
@nl
prefLabel
Quantitative multiplexed analy ...... a large retrospective cohort.
@en
Quantitative multiplexed analy ...... a large retrospective cohort.
@nl
P2093
P2860
P356
P1433
P1476
Quantitative multiplexed analy ...... a large retrospective cohort.
@en
P2093
Christopher B Moeder
David L Rimm
Jennifer M Giltnane
Robert L Camp
P2860
P304
P356
10.1002/CNCR.24277
P407
P577
2009-06-01T00:00:00Z